key: cord-1055005-x4revujn
authors: Zhang, Yi; Jiang, Ning; Qi, Weiqiang; Li, Tao; Zhang, Yumeng; Zhang, Haocheng; Wu, Jing; Zhu, Zhaoqin; Ai, Jingwen; Qiu, Chao; Zhang, Wenhong
title: Intra-host SARS-CoV-2 Single-Nucleotide Variants Emerged During the Early Stage of COVID-19 Pandemic Forecast Population Fixing Mutations
date: 2022-01-15
journal: J Infect
DOI: 10.1016/j.jinf.2022.01.016
sha: 43c4d62fd925d95a0984f01c9f2762f5c4b2bb22
doc_id: 1055005
cord_uid: x4revujn

nan

We read with great interest the recent study by J Zhu et al (1) . reported that SARS-CoV-2 in saliva from infected patients presented viral load dynamics. With error-prone polymerase and recombination events occurring during the replication, the SARS-CoV-2 has been continuously spreading across populations. The highly diversity of SARS-CoV-2 genome leads to worries of emerging strains with high transmissibility or those escaping from immunity induced by infection or vaccination.

Intra-host single-nucleotide variant variants (iSNVs) that appear during the course of infection might provide valuable information on distinguishing mixed founder viruses, their potential of escaping immune response, as well as potential clues for drug designing (2) (3) (4) . A sub-lineage of SARS-CoV-2 was first defined by T4959 mutation that appeared as an iSNV in two individuals in Massachusetts (5) . Additionally, studies of intra-host diversity have revealed that the most iSNVs are either lost, or occasionally fixed as population dominant mutations (6) . Collectively, these observations suggest that close monitoring of iSNVs would help predict dominant 4 mutations and gain time in besieging and addressing variants of concern.

Here, taking advantage of iSNVs profiles from specimens collected from January 2020 to March 2020, the early stage of the pandemic, we investigated the use of iSNVs in predicting mutations that can be fixed at the population level. Sixty-three confirmed COVID-19 patients from domestic cases and oversea importation cases admitted to Huashan Hospital or Shanghai Public Health Clinical Center from January to March 2020 were included in this study. Viral RNA was isolated from patients' sputum or nasopharyngeal swabs and amplicon sequencings were performed on Illumina Nova-seq Platform (Illumina, USA). This study was approved by the ethical committee of Huashan Hospital.

Raw sequencing data were filtered and mapped to the reference genome (Accession number: NC_045512.1). Bowtie2 (v 2.3.3.1) was used for mapping reads and candidate SNPs were identified using SAMtools (v 1.9). The number of mapping reads, mapping ratio, sequence coverage, and depth were generated to evaluate the quality of specimens. The iSNVs sites were determined as described earlier(2, 3); briefly, first, criteria of Phred Quality Score (base quality and mapping quality) ≥ 20 and ≥ 200x depth were met. Second, (1) minor allele frequency ≥5%, (2) at least ten reads to support the minor allele, and finally, (3) strand bias of the minor allele and reads with major allele < 10-folds. Additionally, iSNVs positioned in the 20 bp 5 upstream and downstream of the primers-targeted SARS-CoV-2 genome region was removed. The annotations were made using the reference genome available at NCBI (NC_045512.1). The data related to fixed SARS-CoV-2 mutation sites deposited by November 8th, 2021 were downloaded from National Genomics Data Center (7).

Overall, 836 iSNV sites were identified among specimens obtained from 61 patients. (Table 1) . Other variants either 'reverted' in subsequent infections or did not transmit as effectively during onward transmission. Four sites were considered as lineage-specific fixed mutation with existence in more than 1% strains. These four iSNVs, 10029 (ORF1ab: T3255I), 11418(ORF1ab: V3718A), 26149 (ORF3a: S253P) and 28932 (N: A220V) were non-synonymous regarding change in amino acids (Figure 1a and 1b) . Based on the emergence and time-line of these fixed SNPs, we inferred that among the 29 iSNVs, 16 iSNVs occurred in our samples far before fixing consensus SNPs emerged. Time-line wise, the other 13 iSNVs were observed close to the emergence of fixed mutations, but before the progression to fixation (Table 1) . Apart from the lineage-specific mutations, four iSNVs (21789, 22088, 22992, and 24334) were located at the region encoding the spike protein, which may help in immune escape, especially iSNV 22992 (S: S477N) (8, 9) .

Among publicly available sequenced database that had been deposited 18 months into the COVID-19 pandemic, we identified several intra-host variants that were eventually fixed, and their proportion increased in population. Among these, substitutions in the receptor binding domain (RBD) attracted our attention as they 

Viral dynamics of SARS-CoV-2 in saliva from infected patients

Intra-host variation and evolutionary dynamics of SARS-CoV-2 populations in

Intra-host dynamics of Ebola virus during

Evolution of viral quasispecies during SARS-CoV-2 infection

Evidence of transmission from fully vaccinated individuals in a large outbreak of the SARS-CoV-2 Delta variant in Provincetown, Massachusetts. medRxiv

SARS-CoV-2 within-host diversity and transmission

The Global Landscape of SARS-CoV-2 Genomes, Variants, and Haplotypes in 2019nCoVR

Prospective mapping of viral mutations that escape antibodies used to treat COVID-19

SARS-CoV-2 variants, spike mutations and immune escape

Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2